NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before...
A critical RCE vulnerability (CVE-2025-14500) in IceWarp, an EU-made business communication and collaboration platform, may be exploited by attackers to gain unauthorized access to exposed unpatched servers. According to the Shadowserver Foundation, there are currently over 1,200 internet-facing instances that have yet to receive a fix, and the organization is sending out alerts to the owners, urging them to update. About CVE-2025-14500 IceWarp, developed by the Czech company of the same name, is a business ... More →The post Over 1,200 IceWarp servers still vulnerable to unauthenticated RCE flaw (CVE-2025-14500) appeared first on Help Net Security.
Shrinking the carbon footprint of chemical manufacturing with lasers, solar radiation Illinois News Bureau
Leo UK builds new campaign around real phone galleries that often lead to a McDonald’s stop.
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Nikola Cesarovic, PhD, will present clinical feasibility and outcome data at the Cardiovascular Research Technologies (CRT) 2026 Meeting, happening March 7-10, 2026, in Washington, DC.The abstract titled, "Novel Technique For Transvascular Peripheral Nerve Neurolysis Using Radiofrequency (RF) Ablation: Clinical Feasibility And Outcomes,” will be presented during the Top Abstract Session (S194) on Saturday, March 7 from 2:18 - 2:24p ET for Hypertension Therapies and Renal Denervation session. Dr. Cesarovic will deliver a six-minute presentation, highlighting clinical feasibility and early outcomes associated with a novel RF-based approach designed to selectively disrupt peripheral nerve activity via a transvascular approach. Autonomix’s technology is engineered to identify and target specific nerve signals, potentially enabling differentiated therapeutic precision compared to conventional ablation techniques."This Top Abstract selection underscores the growing clinical interest in precision nerve-targeted therapies and highlights the potential of Autonomix’s platform to enable controlled, transvascular peripheral nerve modulation,” said Dr. Robert Schwartz, Co-Founder and Chief Medical Officer of Autonomix. "We believe these early feasibility findings support the broader applicability of our technology across multiple indications where peripheral nerve signaling plays a critical role.”CRT is one of the world’s leading educational forums for interventional cardiovascular medicine, with Top Abstract podium selections representing the highest-scoring submissions based on scientific merit, innovation and clinical relevance. For more information, please visit the conference website here.About Autonomix Medical, Inc.Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.Forward Looking StatementsSome of the statements in this release are "forward-looking statements,” which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as "should,” "might,” "may,” "intends,” "anticipates,” "believes,” "estimates,” "projects,” "forecasts,” "expects,” "plans,” and "proposes.” Forward-looking statements in this press release include expectations regarding the potential effectiveness and clinical benefits of Autonomix's nerve-targeted treatments for pancreatic cancer pain and other conditions.Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors” and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 29, 2025, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of this press release and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.Investor and Media ContactJTC Team, LLCJenene Thomas908.824.0775autonomix@jtcir.com
The Middle East remains one of the most militarized regions in the world, with several nations maintaining large, technologically advanced, and well-funded armed forces. The post 10 Middle East countries with most powerful militaries in 2026 appeared first on Vanguard News.
Jio aims to become the world's largest AI token generator, arguing telecom economics are shifting from minutes and data to tokens in the emerging AI-driven digital economy.
AI everywhere, a revamped interface and much, much more.
American Axle & Manufacturing (NYSE:DCH – Get Free Report) is one of 32 public companies in the “Motor Vehicle Parts & Accessories” industry, but how does it weigh in compared to its competitors? We will compare American Axle & Manufacturing to related businesses based on the strength of its dividends, analyst recommendations, valuation, earnings, institutional [...]
WhatsApp Business could potentially start charging users who want to link more than four devices to the same account in a future update.
A bug in Google Messages is causing severe battery drain and overheating on some devices. Here's a temporary fix while you wait for Google to push an update.
Redmi 10 Power Price in India: Redmi has launched its new smartphone Redmi 10 Power in India. The smartphone was launched along with Redmi 10A, on Wednesday, 20 April in India
The premium Alienware m15 R7 and m17 R5 highlight four new Ryzen-powered systems.
Apple is offering its new firmware update for the MagSafe accessory that promises to give you faster charging for the compatible iPhone models.
System apps with native call-recording functionality remain unaffected.
The OnePlus Nord 2T India launch may take place soon as the moniker has been spotted on the TDRA certification. The OnePlus Nord 2T's camera details have also been leaked. Here are the expected specifications of the device.
The iPhone 16 is likely to be the first Apple device to skip the camera notch.
Garena Free Fire Max redeem codes are 12-digit codes that are region-specific and can be used by players to gain an edge over rivals in every round of the battle royale game.
We are still not sure that no-charger policy will be limited to Narzo 50A Prime or it will be extended to other Realme budget, mid-segment and premium phones
